Key result
Beyond 1 year post-surgery, mitral valve replacement was associated with decreased survival compared to valve repair for native mitral infective endocarditis.
Why the study?
The survival benefit of mitral valve repair over replacement in native active infective endocarditis is poorly established and possibly absent due to risks of repair failure and reoperation.
Does mitral valve repair improve overall survival compared to mitral valve replacement in patients with native mitral infective endocarditis?
Cohort (n=149)
Does mitral valve repair improve overall survival compared to mitral valve replacement in patients with native mitral infective endocarditis?
In patients with native mitral infective endocarditis, a structured approach enabling mitral valve repair is associated with improved long-term survival beyond 1 year compared to valve replacement.
Answers are grounded in this paper and cite their sources.
Structured approach enables mitral repair in two-thirds of active IE cases; leaves open whether earlier intervention improves durability.
OBJECTIVES: Mitral valve repair in native active infective endocarditis is technically challenging. The survival benefit over valve replacement is poorly established and possibly absent because of the high risk of repair failure and reoperation. In this study, we explore the results of our structured approach in these patients. METHODS: Between January 2000 and January 2017, 149 patients underwent surgery for native mitral infective endocarditis. Among them, 97 (66%) patients underwent valve repair and 52 (34%) underwent valve replacement. Our structured approach consisted of early surgery, radical resection of infected tissue, liberal use of prosthetic materials and 'patch' repair techniques. A critical assessment of expected repair durability was made intraoperatively and repair was not performed if concerns of long-term durability existed. To study the effects of valve repair on overall survival, landmark analysis was performed. RESULTS: In-hospital mortality was 15.4% (14 repair vs 9 replacement patients; P = 0.642). There were no residual infective endocarditis cases or early reoperations. On Cox proportional hazards analysis, valve replacement was not inferior to repair within 1-year post-surgery [hazard ratio (HR) 1.134, 95% confidence interval (CI) 0.504-2.540; P = 0.76]. Beyond 1 year post-surgery, replacement was associated with decreased survival (HR 2.534, 95% CI 1.002-6.406; P = 0.049). There were no differences in freedom from recurrent infective endocarditis (P = 0.47) and mitral valve reintervention (P = 0.52). CONCLUSIONS: Active mitral valve endocarditis remains a complex disease with significant early and late morbidity and mortality. A structured approach allows valve repair in two-thirds of patients. Clinical results could be improved by focussing on early surgery, prior to extensive valve destruction, to enable durable repairs and improve late outcomes.
No takes yet. Share an insight, caveat, or question.
Defauw et al. (2020) conducted a cohort in Native mitral infective endocarditis (n=149). Mitral valve replacement vs. Mitral valve repair was evaluated on Survival beyond 1 year post-surgery (HR 2.534, 95% CI 1.002-6.406, p=0.049). Beyond 1 year post-surgery, mitral valve replacement was associated with decreased survival compared to valve repair for native mitral infective endocarditis.
Synapse has enriched 10 related papers. Consider them for comparative context: